title: Avascular necrosis of the femoral head in patients with Hodgkin's disease.
abstract: Avascular necrosis of the femoral head (ANFH) is a rare complication that may occur in patients diagnosed with Hodgkin's Disease (HD), as a result of treatment. A review was made of 315 cases of HD treated with systemic chemotherapy associated with high doses of steroids and radiation therapy and 18 patients (5.71%) were found to have developed ANFH during treatment. The mean follow-up time for chemotherapy was 40 months (range 20-110 months) with an average dose of prednisone of 8.45 g (range 3.20 - 18.50). The patients were treated by simple forage, simple forage plus IES and total hip arthroplasty (THA). In 8 cases (44.44%) forage associated with IES was performed as the initial treatment option and 6 of these cases were found to be in Ficat stage II (75%), 1 was found to be in stage III (12.55%) and another in stage IV (12.5%). In 2 cases, the central decompression technique was used (Simple Forage); both were in Ficat stage II. In the other 8 cases, a total hip arthroplasty (THA) was chosen as the initial treatment option, with 3 of these patients in Ficat stage III and 5 in Ficat stage IV. The clinical outcomes (time to postoperative pain, time to radiological failure, and time to arthroplasty from the forage) following surgical management using the forage-biopsy technique with and without internal electrostimulation (IES) were recorded. We observed that treatment with Forage + IES was better than simple Forage in stages below III in patients with Hodgkin's Disease. We considered that in Ficat stage III and IV arthroplasty (THA) was the better option. Steroids do not appear to be the only factor that worsens the outcomes of the parameters tested, and, in our opinion, other associated factors exist.
authors.affiliation: Facultativo Especialista Cirugía Ortopédica y Traumatología, Hospital Marques de Valdecilla, Santander, Spain. rjgarciarenedo@hotmail.com
authors.forename: Raúl J G
authors.initials: RJ
authors.lastname: Renedo
authors.forename: Mario M
authors.initials: MM
authors.lastname: Sousa
authors.forename: Salvador F
authors.initials: SF
authors.lastname: Pérez
authors.forename: Juan R
authors.initials: JR
authors.lastname: Zabalbeascoa
authors.forename: Luis P
authors.initials: LP
authors.lastname: Carro
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D019644:Arthroplasty, Replacement, Hip; D019299:Decompression, Surgical; D004599:Electric Stimulation Therapy; D005260:Female; D005271:Femur Head Necrosis / Q000209:etiology / Q000473:pathology* / Q000628:therapy; D005938:Glucocorticoids / Q000009:adverse effects; D006689:Hodgkin Disease / Q000150:complications / Q000473:pathology* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000009:adverse effects; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D005938:Glucocorticoids; D011241:Prednisone